A Phase II, safety, efficacy trial of ANS-6637 for opioid misuse
Phase of Trial: Phase II
Latest Information Update: 25 Sep 2018
At a glance
- Drugs ANS 6637 (Primary)
- Indications Opioid abuse
- Focus Adverse reactions; Therapeutic Use
- Acronyms SEARCH
- 25 Sep 2018 New trial record
- 19 Sep 2018 According to an Amygdala Neurosciences media release, the project is led by Dr. Henry Masur, Chief of the NIH Critical Care Medicine Department and Dr. Shyam Kottilil (University of Maryland School of Medicine) and being conducted by the NIH Clinical Center and the Institute of Human Virology (IHV) at the University of Maryland School of Medicine.
- 19 Sep 2018 According to an Amygdala Neurosciences media release, this trial is being conducted under The SEARCH program of clinical studies and will receive up to $12.4 million of funding from the NIH HEAL (Helping to End Addiction Long-term) initiative.